Indocyanine Green Patent Expiration

Indocyanine Green is used for visualizing blood flow in various surgical procedures and organ transplants. It was first introduced by Renew Pharmaceuticals Ltd in its drug Ic-Green on Approved Prior to Jan 1, 1982. Another drug containing Indocyanine Green is Spy Agent Green Kit. 2 different companies have introduced drugs containing Indocyanine Green.


Indocyanine Green Patents

Given below is the list of patents protecting Indocyanine Green, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Spy Agent Green Kit US11712320 Methods and systems to automate surgical interventions Jul 14, 2039 Novadaq Tech
Spy Agent Green Kit US10631746 Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography Aug 04, 2035 Novadaq Tech
Spy Agent Green Kit US8406860 Method for evaluating blush in myocardial tissue Apr 09, 2029 Novadaq Tech
Spy Agent Green Kit US8647605 Real time imaging during solid organ transplant Feb 11, 2029 Novadaq Tech
Spy Agent Green Kit US8185176 Method and apparatus for vasculature visualization with applications in neurosurgery and neurology Jun 04, 2028 Novadaq Tech
Spy Agent Green Kit US9421280 Real time imaging during solid organ transplant Nov 24, 2025 Novadaq Tech
Spy Agent Green Kit US7881777 Method and apparatus for performing intra-operative angiography Sep 22, 2021

(Expired)

Novadaq Tech
Spy Agent Green Kit US6915154 Method and apparatus for performing intra-operative angiography Aug 01, 2021

(Expired)

Novadaq Tech
Spy Agent Green Kit US8892190 Method and apparatus for performing intra-operative angiography Aug 11, 2020

(Expired)

Novadaq Tech



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Indocyanine Green's patents.

Given below is the list recent legal activities going on the following patents of Indocyanine Green.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 07 Feb, 2024 US9421280
Payment of Maintenance Fee, 4th Year, Large Entity 11 Oct, 2023 US10631746
Recordation of Patent eGrant 01 Aug, 2023 US11712320
Patent eGrant Notification 01 Aug, 2023 US11712320
Mail Patent eGrant Notification 01 Aug, 2023 US11712320
Email Notification 01 Aug, 2023 US11712320
Recordation of Patent Grant Mailed 01 Aug, 2023 US11712320
Patent Issue Date Used in PTA Calculation 01 Aug, 2023 US11712320
Electronic Review 01 Aug, 2023 US11712320
Electronic Review 13 Jul, 2023 US11712320


Indocyanine Green's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Indocyanine Green Generics

Only one generic application has been filed for Indocyanine Green.

Given below is the list of companies who have filed for Indocyanine Green generic.


1. RENEW PHARMS

Renew Pharmaceuticals Ltd has filed for 1 generic for Indocyanine Green. Given below are the details of the strengths of this generic introduced by Renew Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG/VIAL

(reference standard)

injectable Prescription INJECTION N/A Nov 21, 2007